NVO: Ziltivekimab Fails to Show MACE Risk Reduction
NVO's ziltivekimab misses MACE risk reduction target
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.